Skip to main content
All lobbying filings

Harbinger Strategies, LLC

Harbinger Strategies, LLC filed a Q4 termination report for CSL Behring LLC on January 20, 2026, reporting $50,000 in lobbying income.

Lobbying for CSL Behring LLC · Biopharmaceutical company

As filed: HARBINGER STRATEGIES, LLC for CSL BEHRING LLC.

All filings by Harbinger Strategies, LLC · Everything CSL Behring LLC has reported

 Filing · LD-2 quarterly report Q4 termination
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
Pennsylvania
Representation ended
Dec 31, 2025
The registrant reported terminating its work for this client.

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

The PLASMA Act (H.R.1476/S.694): issues related to Part D and plasma-derived therapies.

 Bills named in this filing 2

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem